Carbylan Therapeutics Obtains $65,000,000 New Financing

  • Feed Type
  • Date
    4/9/2015
  • Company Name
    Carbylan Therapeutics
  • Mailing Address
    3181 Porter Drive Palo Alto, CA 94304 USA
  • Company Description
    Carbylan Therapeutics (NASDAQ: CBYL) develops and markets bioresponsive medical products to enhance healing, provide better surgical outcomes and improve patients’ quality of life. Carbylan is committed to quality in all areas of its business by complying with regulatory requirements and improving the effectiveness of its quality system.
  • Website
    http://www.carbylan.com
  • Transaction Type
    IPO
  • Transaction Amount
    $65,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms